Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: A double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF)
Frank Edelmann, Albrecht G. Schmidt, Götz Gelbrich, Lutz Binder, Christoph Herrmann-Lingen, Martin Halle, Gerd Hasenfuss, Rolf Wachter, Burkert Pieske
Research output: Contribution to journal › Article › peer-review
65Scopus
citations
Fingerprint
Dive into the research topics of 'Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: A double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF)'. Together they form a unique fingerprint.